177 related articles for article (PubMed ID: 38634216)
1. Trends in colorectal cancer screening compliance and incidence among 60- to 74-year-olds in China.
Zhang M; Zhang Y; Guo L; Zhao L; Jing H; Yang X; Zhang W; Zhang Y; Nie Z; Zhu S; Zhang S; Zhang X
Cancer Med; 2024 Apr; 13(8):e7133. PubMed ID: 38634216
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and risk factors of colorectal neoplasia in individuals aged 40-49 years: Findings from screening program in China.
Zhang M; Zhang Y; Zhang W; Zhang Y; Zhao L; Jing H; Gao X; Nie Z; Zhu S; Zhang S; Zhang X
J Gastroenterol Hepatol; 2024 Apr; 39(4):694-700. PubMed ID: 38200678
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].
Zhu N; Huang YQ; Song YM; Zhang SZ; Zheng S; Yuan Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):612-620. PubMed ID: 35844124
[No Abstract] [Full Text] [Related]
4. [Compliance rate of screening colonoscopy and its associated factors among high-risk populations of colorectal cancer in urban China].
Chen HD; Li N; Ren JS; Shi JF; Zhang YM; Zou SM; Zheng ZX; Zhang K; Dai M
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Mar; 52(3):231-237. PubMed ID: 29973000
[No Abstract] [Full Text] [Related]
5. [Results and cost-effectiveness of colorectal cancer screening program among urban residents in Zhejiang province, 2013-2018].
Wang L; Li HZ; Zhu C; Wang YQ; Zhou HJ; Sun XH; Zhang MZ; Jin L; Du LB
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Dec; 41(12):2080-2086. PubMed ID: 33378820
[No Abstract] [Full Text] [Related]
6. Postponing colonoscopy for 6 months in high-risk population increases colorectal cancer detection in China.
Zhang M; Zhang Y; Zhang W; Zhao L; Jing H; Wu X; Guo L; Zhang H; Zhang Y; Zhu S; Zhang S; Zhang X
Cancer Med; 2023 May; 12(10):11816-11827. PubMed ID: 36951442
[TBL] [Abstract][Full Text] [Related]
7. Age- and sex-stratified detection rates and associated factors of colorectal neoplasia in the Tianjin colorectal cancer screening program from 2012 to 2020.
Yuan Z; Wang S; Wang Y; Li H; Gao W; Liu X; Han Y; Liu Z; Zhang Q; Ma H; Wang J; Wei X; Zhang X; Cui W; Zhang C
BMC Gastroenterol; 2023 Dec; 23(1):435. PubMed ID: 38087194
[TBL] [Abstract][Full Text] [Related]
8. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
[TBL] [Abstract][Full Text] [Related]
9. Risk of Colorectal Neoplasia in Individuals With Self-Reported Family History: A Prospective Colonoscopy Study from 16 Asia-Pacific Regions.
Wong MC; Ching JY; Chiu HM; Wu KC; Rerknimitr R; Li J; Wu DC; Goh KL; Matsuda T; Kim HS; Leong R; Yeoh KG; Chong VH; Sollano JD; Ahmed F; Menon J; Ng SC; Wu JC; Chan FK; Sung JJ
Am J Gastroenterol; 2016 Nov; 111(11):1621-1629. PubMed ID: 26977757
[TBL] [Abstract][Full Text] [Related]
10. Detection of cancers and advanced adenomas in asymptomatic participants in colorectal cancer screening: a cross-sectional study.
Schult AL; Botteri E; Hoff G; Randel KR; Dalén E; Eskeland SL; Holme Ø; de Lange T
BMJ Open; 2021 Jul; 11(7):e048183. PubMed ID: 34210732
[TBL] [Abstract][Full Text] [Related]
11. Motives for non-adherence to colonoscopy advice after a positive colorectal cancer screening test result: a qualitative study.
Bertels L; Lucassen P; van Asselt K; Dekker E; van Weert H; Knottnerus B
Scand J Prim Health Care; 2020 Dec; 38(4):487-498. PubMed ID: 33185121
[TBL] [Abstract][Full Text] [Related]
12. Baseline Colonoscopy Findings Associated With 10-Year Outcomes in a Screening Cohort Undergoing Colonoscopy Surveillance.
Lieberman D; Sullivan BA; Hauser ER; Qin X; Musselwhite LW; O'Leary MC; Redding TS; Madison AN; Bullard AJ; Thomas R; Sims KJ; Williams CD; Hyslop T; Weiss D; Gupta S; Gellad ZF; Robertson DJ; Provenzale D
Gastroenterology; 2020 Mar; 158(4):862-874.e8. PubMed ID: 31376388
[TBL] [Abstract][Full Text] [Related]
13. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer screening in a low-incidence area: general invitation versus family risk targeting: a comparative study from Montenegro.
Panic N; Rösch T; Smolovic B; Radunovic M; Bulajic M; Pavlovic-Markovic A; Krivokapic Z; Djuranovic S; Ille T; Bulajic M
Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1222-5. PubMed ID: 26067224
[TBL] [Abstract][Full Text] [Related]
15. Factors Associated With Colonoscopy Compliance Based on Health Belief Model in a Community-Based Colorectal Cancer Screening Program Shanghai, China.
He L; Gao S; Tao S; Li W; Du J; Ji Y; Wang Y
Int Q Community Health Educ; 2020 Oct; 41(1):25-33. PubMed ID: 31876256
[TBL] [Abstract][Full Text] [Related]
16. [Rates on the acceptance of colonoscopy, fecal immunochemical test and a novel risk-adapted screening approach in the screening programs of colorectal cancer as well as related associated factors].
Chen HD; Lu M; Liu CC; Zhang YH; Zou SM; Shi JF; Ren JS; Li N; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct; 41(10):1655-1661. PubMed ID: 33297622
[No Abstract] [Full Text] [Related]
17. [Participation rate and detection of colorectal neoplasms based on multi-round fecal immunochemical testing for colorectal cancer screening in the Chinese population].
Li N; Zhou YY; Lu M; Zhang YH; Lu B; Luo CY; Luo JH; Cai J; Chen HD; Dai M
Zhonghua Zhong Liu Za Zhi; 2023 Dec; 45(12):1041-1050. PubMed ID: 38110312
[No Abstract] [Full Text] [Related]
18. Colorectal neoplasia prevalence in a predominantly Hispanic community: Results from a colorectal cancer screening program in Texas.
Willauer AN; Zuckerman MJ; Alomari A; Alvarado LA; Salaiz R; Casner N; Dwivedi AK; Shokar NK
Am J Med Sci; 2022 Oct; 364(4):394-403. PubMed ID: 35398033
[TBL] [Abstract][Full Text] [Related]
19. Synthetic indicator of the impact of colorectal cancer screening programmes on incidence rates.
Zorzi M; Zappa M;
Gut; 2020 Feb; 69(2):311-316. PubMed ID: 31040168
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]